Washington Trust’s QuidelOrtho QDEL Stock Holding History

Washington Trust’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21	Closed	-$1.8K	–	986
2022 Q4	$1.8K	Hold	21	–	–	﹤0.01%	825
2022 Q3	$2K	Buy	+21	New	+$1.88K	﹤0.01%	808

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Washington Trust's QDEL Position: Q1 2023 in Review

Washington Trust sold out of QuidelOrtho (QDEL) in Q1 2023, closing a stake of 21 shares — an estimated $1.8K sold.

Washington Trust first reported a position in QDEL in Q3 2022 and held it in 2 quarters. The position peaked at $2K in Q3 2022. 331 funds tracked by Wall St. Rank hold QDEL as of Q1 2023.

Washington Trust reported no remaining QuidelOrtho position as of Q1 2023 after selling out during the quarter.
Washington Trust sold 21 QuidelOrtho shares in Q1 2023, an estimated $1.8K.
Washington Trust first reported a position in QuidelOrtho in Q3 2022 and held it in 2 quarters.
Washington Trust's QuidelOrtho position peaked at $2K in Q3 2022.
331 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2023.

Based on Washington Trust's 13F filing for Q1 2023, filed 4 May 2023.